Patient attitudes and adherence to treatment across six chronic inflammatory diseases

AbbVie announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases, adherence to treatment was generally higher in patients being treated with tumour necrosis factor inhibitors compared with patients treated with conventional therapy.

Source: Pharmacy Europe - June 12, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Rheumatology AbbVie ALIGN chronic immune-mediated inflammatory disease Latest News tumour necrosis factor inhibitors Source Type: news